Intuitive Surgical (NASDAQ:ISRG) Shares Gap Down After Analyst Downgrade

Posted by Brian Himes on Jul 17th, 2026

Intuitive Surgical, Inc. (NASDAQ:ISRG – Get Free Report)’s share price gapped down before the market opened on Friday after Stifel Nicolaus lowered their price target on the stock from $670.00 to $550.00. The stock had previously closed at $402.33, but opened at $365.03. Stifel Nicolaus currently has a buy rating on the stock. Intuitive Surgical shares last traded at $355.9240, with a volume of 2,263,369 shares.

Several other equities research analysts have also weighed in on the stock. Evercore set a $430.00 target price on shares of Intuitive Surgical in a report on Monday, July 6th. Wells Fargo & Company reissued an “overweight” rating and set a $487.00 price target on shares of Intuitive Surgical in a report on Friday. Robert W. Baird reduced their price target on shares of Intuitive Surgical from $525.00 to $500.00 and set an “outperform” rating on the stock in a research report on Friday. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Intuitive Surgical in a report on Tuesday, May 19th. Finally, Barclays set a $651.00 target price on shares of Intuitive Surgical and gave the company an “overweight” rating in a research note on Thursday, April 23rd. One investment analyst has rated the stock with a Strong Buy rating, twenty have given a Buy rating, seven have issued a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $530.92.

Get Our Latest Stock Report on ISRG

Insider Buying and Selling

In other Intuitive Surgical news, Director Amy L. Ladd sold 500 shares of the firm’s stock in a transaction dated Tuesday, April 28th. The shares were sold at an average price of $473.46, for a total value of $236,730.00. Following the completion of the sale, the director owned 239 shares in the company, valued at approximately $113,156.94. This trade represents a 67.66% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Gary Loeb sold 400 shares of the business’s stock in a transaction dated Wednesday, June 10th. The stock was sold at an average price of $424.14, for a total transaction of $169,656.00. Following the completion of the transaction, the executive vice president directly owned 5,720 shares of the company’s stock, valued at approximately $2,426,080.80. This represents a 6.54% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 7,169 shares of company stock worth $3,059,135 in the last 90 days. Corporate insiders own 0.60% of the company’s stock.

Intuitive Surgical News Summary

Here are the key news stories impacting Intuitive Surgical this week:

Positive Sentiment: Intuitive Surgical reported stronger-than-expected Q2 results, with revenue and profit topping estimates on continued demand for its da Vinci robotic surgery systems. The company also said worldwide procedures grew solidly, including strong growth in Ion and da Vinci usage. Reuters article
Positive Sentiment: Several Wall Street firms still kept bullish ratings after trimming price targets, including Stifel, Citi, BTIG, Baird, Leerink, Sanford Bernstein, and Truist, suggesting analysts continue to see upside from current levels despite the pullback. Benzinga analyst target updates
Neutral Sentiment: Management maintained its 2026 forecast for procedure growth, which signals confidence in the long-term story, but it did not raise guidance enough to fully satisfy investors. Reuters article
Negative Sentiment: Shares are falling because the company warned that changes to some insurance plans could slow U.S. procedure growth, raising concerns that near-term demand may be weaker than hoped. Reuters article
Negative Sentiment: Investor sentiment was also dampened by the company’s procedure-growth outlook, which appears to have missed elevated expectations despite the earnings beat, leading to a selloff in the stock. Invezz article

Institutional Inflows and Outflows

Institutional investors have recently bought and sold shares of the stock. State Street Corp lifted its holdings in Intuitive Surgical by 1.0% during the 4th quarter. State Street Corp now owns 15,701,591 shares of the medical equipment provider’s stock worth $8,892,753,000 after buying an additional 162,264 shares in the last quarter. Capital World Investors raised its position in shares of Intuitive Surgical by 1.7% during the fourth quarter. Capital World Investors now owns 7,856,018 shares of the medical equipment provider’s stock worth $4,449,491,000 after acquiring an additional 127,526 shares during the last quarter. Norges Bank acquired a new position in shares of Intuitive Surgical during the fourth quarter valued at $2,856,987,000. Invesco Ltd. lifted its stake in shares of Intuitive Surgical by 17.4% during the fourth quarter. Invesco Ltd. now owns 4,128,735 shares of the medical equipment provider’s stock valued at $2,338,350,000 after acquiring an additional 611,268 shares during the period. Finally, Bank of America Corp DE boosted its holdings in Intuitive Surgical by 3.3% in the first quarter. Bank of America Corp DE now owns 3,616,973 shares of the medical equipment provider’s stock valued at $1,667,388,000 after acquiring an additional 116,292 shares during the last quarter. Institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Stock Down 10.7%

The firm has a fifty day moving average of $417.37 and a 200-day moving average of $468.74. The firm has a market cap of $127.25 billion, a P/E ratio of 43.62, a PEG ratio of 3.16 and a beta of 1.46.

Intuitive Surgical (NASDAQ:ISRG – Get Free Report) last announced its quarterly earnings data on Tuesday, April 21st. The medical equipment provider reported $2.50 earnings per share for the quarter, topping the consensus estimate of $2.08 by $0.42. Intuitive Surgical had a return on equity of 15.98% and a net margin of 28.15%.The firm had revenue of $2.77 billion during the quarter, compared to analysts’ expectations of $2.62 billion. During the same period in the previous year, the business posted $1.81 EPS. The company’s quarterly revenue was up 23.0% compared to the same quarter last year. Sell-side analysts anticipate that Intuitive Surgical, Inc. will post 8.57 EPS for the current year.

Intuitive Surgical Company Profile

(Get Free Report)

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.